Advertisement

Combination of anastrozole and fulvestrant extends survival in women with metastatic breast cancer

00:40 EDT 2 Aug 2012 | The Medical News

Results of a SWOG clinical trial published August 2 in the New England Journal of Medicine show the combination of anastrozole and fulvestrant extended the median survival time of women with hormone receptor-positive metastatic breast cancer by more..

Original Article: Combination of anastrozole and fulvestrant extends survival in women with metastatic breast cancer

NEXT ARTICLE

More From BioPortfolio on "Combination of anastrozole and fulvestrant extends survival in women with metastatic breast cancer"

Search BioPortfolio:
Advertisement
Advertisement